Q1 2025 · 13F-HR
GILEAD SCIENCES, INC. (GILD)holdings as filed
Filed 2025-05-13 · accession 0001123292-25-000217
$1.18B
Reported value
14
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $440.9M | 37.3% | 6,720,803 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $419.4M | 35.5% | 16,707,477 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $246.7M | 20.9% | 31,424,760 | Common | SOLE |
| 045396207 | ASMB | ASSEMBLY BIOSCIENCES INC | $21.1M | 1.79% | 2,209,471 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $19.0M | 1.61% | 452,527 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $8.0M | 0.67% | 4,126,119 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $6.7M | 0.56% | 4,854,443 | Common | SOLE |
| 98422T100 | — | XILIO THERAPEUTICS INC | $6.6M | 0.56% | 9,105,451 | Common | SOLE |
| 482929106 | KLRS | KALARIS THERAPEUTICS INC | $5.8M | 0.49% | 723,273 | Common | SOLE |
| 43906K209 | HOOK | HOOKIPA PHARMA INC | $2.0M | 0.17% | 1,875,945 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $1.7M | 0.14% | 1,156,689 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $1.6M | 0.14% | 5,319,148 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $1.5M | 0.13% | 1,159,145 | Common | SOLE |
| 91864C107 | BRNS | BARINTHUS BIOTHERAPEUTICS PL | $359,758 | 0.03% | 369,855 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.